These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 11861332

  • 1. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A, Mahmoud NG, Goedecke MC, McKeating JA, Strange PG.
    Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
    [Abstract] [Full Text] [Related]

  • 2. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
    Leach K, Charlton SJ, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):881-90. PubMed ID: 17645873
    [Abstract] [Full Text] [Related]

  • 3. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
    Oliveira SH, Lira S, Martinez-A C, Wiekowski M, Sullivan L, Lukacs NW.
    J Leukoc Biol; 2002 Jun 15; 71(6):1019-25. PubMed ID: 12050188
    [Abstract] [Full Text] [Related]

  • 4. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM, Wang ZX, Trent JO, Murray JL, Hu QX, DeLeeuw L, Moore PS, Chang Y, Peiper SC.
    J Mol Biol; 2001 Nov 09; 313(5):1181-93. PubMed ID: 11700073
    [Abstract] [Full Text] [Related]

  • 5. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
    Sarau HM, Rush JA, Foley JJ, Brawner ME, Schmidt DB, White JR, Barnette MS.
    J Pharmacol Exp Ther; 1997 Oct 09; 283(1):411-8. PubMed ID: 9336350
    [Abstract] [Full Text] [Related]

  • 6. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
    Ruffing N, Sullivan N, Sharmeen L, Sodroski J, Wu L.
    Cell Immunol; 1998 Nov 01; 189(2):160-8. PubMed ID: 9790730
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE.
    J Med Virol; 2004 Jun 01; 73(2):300-8. PubMed ID: 15122808
    [Abstract] [Full Text] [Related]

  • 8. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C, Buser R, Power CA, Edgerton M, Buchanan C, Mack M, Simmons G, Clapham PR, Parmentier M, Proudfoot AE.
    J Leukoc Biol; 2001 Jun 01; 69(6):977-85. PubMed ID: 11404385
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins PD, Williams TJ.
    J Immunol; 1999 Mar 01; 162(5):2946-55. PubMed ID: 10072545
    [Abstract] [Full Text] [Related]

  • 10. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB, Glushakova S, Grivel JC, Murphy PM.
    J Clin Invest; 1998 May 01; 101(9):1876-80. PubMed ID: 9576751
    [Abstract] [Full Text] [Related]

  • 11. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M.
    Blood; 1999 Sep 15; 94(6):1899-905. PubMed ID: 10477718
    [Abstract] [Full Text] [Related]

  • 12. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
    Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV.
    Invest Ophthalmol Vis Sci; 2001 Jun 15; 42(7):1547-52. PubMed ID: 11381059
    [Abstract] [Full Text] [Related]

  • 13. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP, Quinton LJ, Shellito JE, Mason CM.
    Tuberculosis (Edinb); 2005 May 15; 85(3):185-95. PubMed ID: 15850756
    [Abstract] [Full Text] [Related]

  • 14. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B.
    J Leukoc Biol; 2004 Sep 15; 76(3):701-8. PubMed ID: 15178708
    [Abstract] [Full Text] [Related]

  • 15. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
    Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE.
    Pediatr Pulmonol; 2004 Feb 15; 37(2):137-48. PubMed ID: 14730659
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
    Chou CC, Fine JS, Pugliese-Sivo C, Gonsiorek W, Davies L, Deno G, Petro M, Schwarz M, Zavodny PJ, Hipkin RW.
    Br J Pharmacol; 2002 Nov 15; 137(5):663-75. PubMed ID: 12381680
    [Abstract] [Full Text] [Related]

  • 17. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
    Haworth B, Lin H, Fidock M, Dorr P, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):891-7. PubMed ID: 17669370
    [Abstract] [Full Text] [Related]

  • 18. RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes.
    Luo Y, Berman MA, Zhai Q, Fischer FR, Abromson-Leeman SR, Zhang Y, Kuziel WA, Gerard C, Dorf ME.
    Glia; 2002 Jul 15; 39(1):19-30. PubMed ID: 12112372
    [Abstract] [Full Text] [Related]

  • 19. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D, Yuan XJ, Evans RJ, Pappas AT, Wang H, Su EW, Hamdouchi C, Venkataraman C.
    BMC Immunol; 2005 Jul 07; 6():15. PubMed ID: 16001983
    [Abstract] [Full Text] [Related]

  • 20. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S, Hamrah P, Miyamoto K, Miyazaki D, Dekaris I, Dawson T, Lu B, Gerard C, Dana MR.
    Invest Ophthalmol Vis Sci; 2005 Apr 07; 46(4):1201-7. PubMed ID: 15790880
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.